The weekly litigation news digest is live. Subscribe now

IP Verse

Medicinal Agent For Treating Amyotrophic Lateral Sclerosis Or Preventing Progression Of Phase Of Amyotrophic Lateral Sclerosis - EP2754440

The patent EP2754440 was granted to Mitsubishi Tanabe Pharma on Apr 3, 2019. The application was originally filed on Sep 5, 2012 under application number EP12830484A. The patent is currently recorded with a legal status of "Revoked".

EP2754440

MITSUBISHI TANABE PHARMA
Application Number
EP12830484A
Filing Date
Sep 5, 2012
Status
Revoked
Oct 13, 2023
Publication Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDDec 19, 2019-ADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0208874
DESCRIPTIONJP2011062529
DESCRIPTIONJPH0531523B
DESCRIPTIONJPS63132833
DESCRIPTIONWO0234264
DESCRIPTIONWO2005075434
INTERNATIONAL-SEARCH-REPORTWO0234264
INTERNATIONAL-SEARCH-REPORTWO2005075434
OPPOSITIONEP1714960
SEARCHEP1714960

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents